Jefferies Financial Group Trims Aurinia Pharmaceuticals (NASDAQ:AUPH) Target Price to $9.00
Aurinia Pharmaceuticals (NASDAQ:AUPH – Free Report) (TSE:AUP) had its price objective decreased by Jefferies Financial Group from $9.50 to $9.00 in a research report report published on Friday, BayStreet.CA reports. Jefferies Financial Group currently has a hold rating on the biotechnology company’s stock. Separately, Royal Bank of Canada lowered their price objective on Aurinia Pharmaceuticals […]
More Stories
Is Sweet Magnolias Season 6 Renewed? Latest News and Review
Netflix’s romantic drama Sweet Magnolias has finally come to an end. In September 2026, Deadline officially announced that one of...
The Inbetweeners 3: Release Date, Cast, Trailer, and Updates
The Inbetweeners 3 is finally coming back on the popular streaming Network, Netflix. The original four stars of the series,...
7 Essential Components of a Modern Corporate Training Tech Stack
What the seven components need to accomplish Your LMS isn’t obsolete. It may simply need to play one part in...
Climate-ready workplaces in 2026: managing heat, flooding, ice and severe weather
Irish and British workplaces are facing severe weather with increasing frequencies, from heatwares and flash flooding to ice underfoot. Preparing...
7 Best Bespoke Smoke Vents for Large and Complex Roof Openings (2026)
Picture a main contractor in Leeds coordinating a logistics warehouse where the structural grid leaves a 2,800 mm clear zone...
6 College Football Teams Generating the Most Betting Interest in 2026
Three weeks into the 2026 college football season, several familiar contenders are already shaping national conversations. Early results have shifted...